Greater Cannabis Company (GCAN) EBITDA Margin (2017 - 2021)
Greater Cannabis Company (GCAN) recorded quarterly EBITDA Margin of 494.65% in Q2 2021, down 190.16% quarter-over-quarter from 170.47% in Q2 2020, and down 32417.0% on a YoY basis from N/an in Q2 2020.
Greater Cannabis Company (GCAN) EBITDA Margin (2017 - 2021) Analysis & Trends
Greater Cannabis Company's EBITDA Margin history runs 5 years deep, the most recent figure standing at 494.65% for Q2 2021.
- In Q2 2021, EBITDA Margin fell 32417.0% year-over-year to 494.65%; the TTM figure through Dec 2021 stood at 2716.91% (down 215651.0% YoY), while the FY2021 annual figure was 2716.91%, down 210402.0% from the prior year.
- EBITDA Margin was 494.65% for Q2 2021 at Greater Cannabis Company, down from 170.47% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 99.52% in Q1 2018 to a low of 43656.16% in Q2 2017.
- Historically, EBITDA Margin has averaged 11043.77% across 5 years, with a median of 494.65% in 2021.
- The sharpest annual moves came in 2018 and 2021: EBITDA Margin jumped 4375550 bps in 2018, then plunged 32417 bps in 2021.
- A 5-year view of EBITDA Margin shows it stood at 28856.62% in 2017, then jumped by 100 bps to 99.34% in 2018, then sank by 4456 bps to 4327.33% in 2019, then jumped by 96 bps to 170.47% in 2020, then slumped by 190 bps to 494.65% in 2021.
- The last three EBITDA Margin figures came in at 494.65% (Q2 2021), 170.47% (Q2 2020), and 4327.33% (Q4 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -170.35% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.25% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Greater Cannabis Company | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -494.65% |
| Jun 30, 2020 | -170.47% |
| Dec 31, 2019 | -4,327.33% |
| Jun 30, 2018 | 99.34% |
| Mar 31, 2018 | 99.52% |
| Sep 30, 2017 | -28,856.62% |
| Jun 30, 2017 | -43,656.16% |